Charger and integrated circuit
    1.
    发明申请
    Charger and integrated circuit 有权
    充电器和集成电路

    公开(公告)号:US20060076928A1

    公开(公告)日:2006-04-13

    申请号:US11221894

    申请日:2005-09-09

    IPC分类号: H02J7/00

    CPC分类号: H02J7/0052 Y10T307/516

    摘要: A charger of the present invention includes a charging transistor and a charging integrated circuit. The charging transistor is series-connected with a secondary battery to supply a charging current to the secondary battery. The charging integrated circuit is incorporated into a package having a higher heat releasability than that of the charging transistor. The charging integrated circuit controls the charging transistor and besides, supplies a charging current to the secondary battery. For this purpose, the charging integrated circuit includes a current source supplying this charging current. The charging current from the current source is supplied to the secondary battery together with the charging current from the charging transistor to charge the secondary battery.

    摘要翻译: 本发明的充电器包括充电晶体管和充电集成电路。 充电晶体管与二次电池串联连接以向二次电池提供充电电流。 充电集成电路被并入具有比充电晶体管更高的散热性的封装。 充电集成电路控制充电晶体管,此外,向二次电池供给充电电流。 为此,充电集成电路包括提供该充电电流的电流源。 来自电流源的充电电流与来自充电晶体管的充电电流一起被提供给二次电池以对二次电池充电。

    Charging control circuit and charging device including charging transistor control unit
    2.
    发明授权
    Charging control circuit and charging device including charging transistor control unit 失效
    充电控制电路和充电装置包括充电晶体管控制单元

    公开(公告)号:US07372235B2

    公开(公告)日:2008-05-13

    申请号:US11348237

    申请日:2006-02-07

    IPC分类号: H01M10/46

    CPC分类号: H02J7/0073

    摘要: A charging control circuit according to an embodiment of the present invention includes a detecting circuit and a charging transistor control unit for controlling a charging transistor supplying a first current, a current source for supplying a second current, and a current source control unit for controlling the current source. For example, if a secondary battery is charged using an adaptor endowed with a current-limiting function, during a constant-current charging period in which a charging voltage of the secondary battery reaches 3.2 V to 4.2 V, the secondary battery is charged with the first current I1, and during a constant-voltage charging period after the voltage reaches 4.2 V, the secondary battery is charged with the first charging current and the second charging current.

    摘要翻译: 根据本发明实施例的充电控制电路包括检测电路和用于控制提供第一电流的充电晶体管的充电晶体管控制单元,用于提供第二电流的电流源和用于控制第一电流的电流源控制单元 当前来源。 例如,如果使用具有限流功能的适配器对二次电池进行充电,则在二次电池的充电电压达到3.2V〜4.2V的恒流充电期间,对二次电池充电 第一电流I 1,并且在电压达到4.2V之后的恒定电压充电时段期间,二次电池充满第一充电电流和第二充电电流。

    Charger and integrated circuit having first and second charging currents
    3.
    发明授权
    Charger and integrated circuit having first and second charging currents 有权
    充电器和集成电路具有第一和第二充电电流

    公开(公告)号:US07554298B2

    公开(公告)日:2009-06-30

    申请号:US11221894

    申请日:2005-09-09

    IPC分类号: H02J7/00

    CPC分类号: H02J7/0052 Y10T307/516

    摘要: A charger of the present invention includes a charging transistor and a charging integrated circuit. The charging transistor is series-connected with a secondary battery to supply a charging current to the secondary battery. The charging integrated circuit is incorporated into a package having a higher heat releasability than that of the charging transistor. The charging integrated circuit controls the charging transistor and besides, supplies a charging current to the secondary battery. For this purpose, the charging integrated circuit includes a current source supplying this charging current. The charging current from the current source is supplied to the secondary battery together with the charging current from the charging transistor to charge the secondary battery.

    摘要翻译: 本发明的充电器包括充电晶体管和充电集成电路。 充电晶体管与二次电池串联连接以向二次电池提供充电电流。 充电集成电路被并入具有比充电晶体管更高的散热性的封装。 充电集成电路控制充电晶体管,此外,向二次电池供给充电电流。 为此,充电集成电路包括提供该充电电流的电流源。 来自电流源的充电电流与来自充电晶体管的充电电流一起被提供给二次电池以对二次电池充电。

    Charging control circuit and charging device
    4.
    发明申请
    Charging control circuit and charging device 失效
    充电控制电路和充电装置

    公开(公告)号:US20060176025A1

    公开(公告)日:2006-08-10

    申请号:US11348237

    申请日:2006-02-07

    IPC分类号: H02J7/00

    CPC分类号: H02J7/0073

    摘要: A charging control circuit according to an embodiment of the present invention includes a detecting circuit and a charging transistor control unit for controlling a charging transistor supplying a first current, a current source for supplying a second current, and a current source control unit for controlling the current source. For example, if a secondary battery is charged using an adaptor endowed with a current-limiting function, during a constant-current charging period in which a charging voltage of the secondary battery reaches 3.2 V to 4.2 V, the secondary battery is charged with the first current I1, and during a constant-voltage charging period after the voltage reaches 4.2 V, the secondary battery is charged with the first charging current and the second charging current.

    摘要翻译: 根据本发明实施例的充电控制电路包括检测电路和用于控制提供第一电流的充电晶体管的充电晶体管控制单元,用于提供第二电流的电流源和用于控制第一电流的电流源控制单元 当前来源。 例如,如果使用具有限流功能的适配器对二次电池进行充电,则在二次电池的充电电压达到3.2V〜4.2V的恒流充电期间,对二次电池充电 第一电流I 1,并且在电压达到4.2V之后的恒定电压充电时段期间,二次电池充满第一充电电流和第二充电电流。

    Systems and methods for detecting watermark formations on semiconductor wafers
    5.
    发明授权
    Systems and methods for detecting watermark formations on semiconductor wafers 失效
    用于检测半导体晶片上的水印构造的系统和方法

    公开(公告)号:US08580696B2

    公开(公告)日:2013-11-12

    申请号:US11829581

    申请日:2007-07-27

    IPC分类号: H01L21/302

    CPC分类号: H01L21/67253

    摘要: Systems and methods for detecting watermark formations on semiconductor wafers are described. In one embodiment, a method comprises providing a semiconductor wafer having at least one watermark sensitive region fabricated thereon, subjecting the wafer to a wet processing step, enhancing a susceptibility to detection of at least one watermark formation created on the at least one watermark sensitive region, and detecting the at least one watermark formation. In another embodiment, a method comprises growing a first oxide layer on a surface of a semiconductor wafer, patterning a watermark sensitive structure on the first oxide layer, depositing a silicon layer over the first oxide layer, doping a region of the silicon layer over the watermark sensitive structure with an impurity to create a watermark sensitive region that is prone to retaining watermark formations as result of a wet processing step, and growing a second oxide layer over the silicon layer.

    摘要翻译: 描述了用于检测半导体晶片上的水印结构的系统和方法。 在一个实施例中,一种方法包括提供具有在其上制造的至少一个水印敏感区域的半导体晶片,对晶片进行湿处理步骤,增强对至少一个水印敏感区域上产生的至少一个水印形成的检测的敏感性 并且检测所述至少一个水印形成。 在另一个实施例中,一种方法包括在半导体晶片的表面上生长第一氧化物层,在第一氧化物层上构图水印敏感结构,在第一氧化物层上沉积硅层,将硅层的区域掺杂在 具有杂质的水印敏感结构,以产生湿式处理步骤结果易于保留水印结构的水印敏感区域,并在硅层上生长第二氧化物层。

    DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL

    公开(公告)号:US20130137122A1

    公开(公告)日:2013-05-30

    申请号:US13747646

    申请日:2013-01-23

    IPC分类号: G01N33/68

    摘要: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.

    NGAL FOR REDUCTION AND AMELIORATION OF ISCHEMIC AND NEPHROTOXIC INJURIES
    7.
    发明申请
    NGAL FOR REDUCTION AND AMELIORATION OF ISCHEMIC AND NEPHROTOXIC INJURIES 失效
    减少和改善化疗和非传染性创伤的NGAL

    公开(公告)号:US20100254970A1

    公开(公告)日:2010-10-07

    申请号:US12817566

    申请日:2010-06-17

    IPC分类号: A61K38/48 A61P13/12

    摘要: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.

    摘要翻译: 使用嗜中性粒细胞明胶酶相关脂质运载蛋白(NGAL)作为治疗剂,以及将治疗,减少或改善选自缺血性损伤,缺血再灌注损伤和毒素诱导的损伤的损伤的方法应用于 患者。 本发明包括以有效治疗,减轻或改善对器官(例如肾)的缺血性,缺血再灌注或毒素诱导的损伤的量向患者NGAL施用。 铁载体可与NGAL共同施用。 本发明还涉及在对患者的器官的缺血或毒素诱导的损伤之后施用形象以增强对NGAL分泌的反应。

    NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
    8.
    发明授权
    NGAL for reduction and amelioration of ischemic and nephrotoxic injuries 有权
    NGAL用于减少和改善缺血性和肾脏损伤

    公开(公告)号:US07776824B2

    公开(公告)日:2010-08-17

    申请号:US11123364

    申请日:2005-05-06

    IPC分类号: A61K38/04 A01N1/00 A01N1/02

    摘要: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.

    摘要翻译: 使用嗜中性粒细胞明胶酶相关脂质运载蛋白(NGAL)作为治疗剂,以及将治疗,减少或改善选自缺血性损伤,缺血再灌注损伤和毒素诱导的损伤的损伤的方法应用于 患者。 本发明包括以有效治疗,减轻或改善对器官(例如肾)的缺血性,缺血再灌注或毒素诱导的损伤的量向患者NGAL施用。 铁载体可与NGAL共同施用。 本发明还涉及在对患者的器官的缺血或毒素诱导的损伤之后施用形象以增强对NGAL分泌的反应。

    DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL

    公开(公告)号:US20100184089A1

    公开(公告)日:2010-07-22

    申请号:US12750241

    申请日:2010-03-30

    IPC分类号: G01N33/573 G01N33/566

    摘要: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.